This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Queen's University at Kingston. Active years: 1998-2002.
Location History:
- Kingston, CA (1998)
- Edmonton, CA (2002)
Company Filing History:
Years Active: 1998-2002
Title: Innovations of Boris I Gorine
Introduction
Boris I Gorine is a notable inventor based in Kingston, CA. He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of amyloidosis. With a total of 2 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
Gorine's latest patents include "Phosphono-carboxylate compounds for treating amyloidosis" and "Nerve process growth modulators." The first patent describes therapeutic compounds and methods for modulating amyloid deposition in a subject, regardless of the clinical setting. This modulation is achieved through the administration of a therapeutic compound that includes a phosphonate group and a carboxylate group. The second patent focuses on nerve process growth modulation using derivatized cyclodextrins, detailing processes for creating sulfated and aminated β-cyclodextrin derivatives.
Career Highlights
Boris I Gorine is affiliated with Queen's University at Kingston, where he conducts his research and development. His work is characterized by a strong focus on innovative therapeutic solutions that address complex medical conditions.
Collaborations
Some of his notable coworkers include Kimberly E Dow and Richard J Riopelle, who contribute to the collaborative research environment at Queen's University.
Conclusion
Boris I Gorine's contributions to the field of therapeutic compounds highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to addressing significant health challenges through research and collaboration.